Quipt Home Medical Corp.

NASDAQ•QIPT

CEO: Mr. Gregory J. Crawford

板块: Healthcare

行业: Medical - Devices

上市日期: 2010-08-10

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

联系方式

1019 Town Drive, Wilder, KY, 41076, United States

859-878-2220

quipthomemedical.com

市值

$161.85M

市盈率 (TTM)

-14.3

29.5

股息率

52周最高

$3.64

52周最低

$1.35

52周范围

100%

排名50Top 68.9%

3.1

F-Score

改良版 Piotroski 分析

基于 10 年期基本面

疲弱 • 3.1 / 9 分

评分区间 (0-9)

8-9: 价值优异

6-7: 基本面强劲

4-5: 整体稳健

0-3: 表现疲弱

数据范围: 2016-2025

财务仪表盘

Q1 2026 数据

营业收入

$111.17M+0.00%

近4季度走势

每股收益

-$0.03+0.00%

近4季度走势

自由现金流

$6.97M+0.00%

近4季度走势

2026 Q1 财报亮点

核心亮点

Revenue Growth Strong Total revenue reached $81.0M USD for the quarter, marking a 32% increase from $61.4M USD last year, driven by recent acquisitions.

Operating Income Improvement Operating income rose substantially to $1.02M USD compared to $448K USD in the prior year period, showing improved core profitability.

Net Loss Slightly Reduced Quarterly net loss decreased marginally to $1.05M USD versus $1.08M USD reported previously, resulting in better basic loss per share.

Stable Operating Cash Flow Net cash flow provided by operating activities was $8.94M USD, remaining relatively flat compared to $9.30M USD last year.

关注风险

Arrangement Closing Uncertainty Consummation of the acquisition agreement is subject to shareholder vote and regulatory approvals; failure could negatively impact share price.

DOJ Investigation Ongoing Company faces a civil investigative demand from the DOJ regarding CPAP equipment claims, posing an uncertain material adverse risk.

Increased Stock Compensation Stock-based compensation expense increased sharply to $982K USD from $207K USD, reflecting new long-term incentive grants.

Operating Restrictions Pending The Arrangement Agreement imposes covenants restricting strategic initiatives until closing, potentially delaying response to market changes.

前瞻展望

Future Growth Priorities Set Priorities focus on driving organic revenue growth, achieving operational net profit, and expanding Adjusted EBITDA beyond current fiscal year.

Post-Acquisition Integration Focus Management is optimizing organizational structure and centralizing back-office processes to support scalable long-term growth following recent deals.

Sufficient Liquidity Expected Current cash on hand of $10.54M USD and credit availability are expected to fund operations for the next twelve months.

Debt Repayment Schedule The $110.0M USD senior credit facility has $84.0M USD outstanding, with scheduled principal repayments commencing in 2026.

同行对比

营业收入 (TTM)

DCGO

$368.09M

-47.0%

QIPT

$315.49M

+31.9%

XTNT

$133.08M

+16.9%

毛利率 (最新季度)

QIPT

97.9%

+104.6pp

MGNX

81.6%

+19.9pp

RCEL

81.2%

-2.4pp

关键指标

股票代码	市值	市盈率 (TTM)	净资产收益率 (TTM)	负债率
PRE	$216.15M	-4.2	-36.0%	1.1%
ANIK	$207.09M	-18.8	-7.4%	12.7%
QIPT	$161.85M	-14.3	-9.9%	41.2%

长期趋势

近4季度

营业收入

净利润

经营现金流

4季度营收复合增长率

24.7%

高速增长

4季度净利润复合增长率

N/M

盈利状态转变

现金流稳定性

100%

现金流表现优异

深度研究

下次财报:2026年5月11日

每股收益:-

营业收入:$104.35M

财务数据

电话会议

财务报告

新闻

利润表

资产负债表

现金流量表

财务比率

变化率

利润表	过去12个月

无数据